Danaher Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Danaher ha aumentado sus beneficios a una tasa media anual de 16.8%, mientras que los beneficios de la industria de Life Sciences han experimentado un crecimiento de 16.4% anual. Los ingresos han ido creciendo a una tasa media de 9.1% al año. La rentabilidad financiera de Danaher es de 7.6%, y sus márgenes netos son de 17.1%.

Información clave

16.8%

Tasa de crecimiento de los beneficios

16.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Life Sciences	21.5%
Tasa de crecimiento de los ingresos	9.1%
Rentabilidad financiera	7.6%
Margen neto	17.1%
Última actualización de beneficios	29 Mar 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Sep 30

Danaher: A Lost Year

Aug 30

Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens

Aug 02

Danaher: A Compounding Icon At A Fair Price

Jul 25

These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well

Jul 13

Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Jun 28

Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump

Jun 22

At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?

Jun 15

Danaher: A Great Chance To Buy This Long-Term Compounder

May 23

With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case

Apr 26

Estimating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Mar 28

Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?

Mar 15

Is Danaher (NYSE:DHR) Using Too Much Debt?

Mar 02

Danaher ups dividend by 8% to $0.27

Feb 22

Danaher Q4 2022 Earnings Preview

Jan 23

Does Danaher (NYSE:DHR) Deserve A Spot On Your Watchlist?

Jan 16

We Have A Winner! Revisiting Danaher And Thermo Fisher

Jan 11

Danaher downgraded to neutral at Credit Suisse on exposure to inventory reductions

Jan 05

A Look At The Fair Value Of Danaher Corporation (NYSE:DHR)

Dec 18

Danaher: A Great Business - The Price Where I Would Buy

Dec 14

Danaher declares $0.25 dividend

Dec 06

When Should You Buy Danaher Corporation (NYSE:DHR)?

Dec 04

Does Danaher (NYSE:DHR) Have A Healthy Balance Sheet?

Nov 20

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Danaher. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NYSE:DHR Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
29 Mar 24	23,737	4,069	7,281	1,498
31 Dec 23	23,890	4,200	7,245	1,503
29 Sep 23	23,520	4,783	6,856	1,444
30 Jun 23	24,310	5,205	6,854	1,447
31 Mar 23	24,904	5,757	6,762	1,460
31 Dec 22	26,643	6,222	7,080	1,528
30 Sep 22	31,250	6,640	8,572	1,787
01 Jul 22	30,816	6,206	8,489	1,808
01 Apr 22	30,283	6,206	8,369	1,803
31 Dec 21	24,802	5,283	6,763	1,498
01 Oct 21	28,065	5,636	7,818	1,643
02 Jul 21	26,720	5,361	7,543	1,544
02 Apr 21	24,799	4,595	7,278	1,441
31 Dec 20	22,284	3,510	6,880	1,348
02 Oct 20	20,392	3,083	6,354	1,246
03 Jul 20	18,886	2,853	5,954	1,186
03 Apr 20	18,034	2,614	5,659	1,146
31 Dec 19	17,911	2,364	5,577	1,126
27 Sep 19	15,562	2,093	4,709	980
28 Jun 19	16,037	2,145	4,880	998
29 Mar 19	16,573	2,166	5,125	1,028
31 Dec 18	17,049	2,406	5,356	1,059
28 Sep 18	19,615	2,761	6,246	1,211
29 Jun 18	19,290	2,669	6,173	1,189
30 Mar 18	18,819	2,553	6,072	1,160
31 Dec 17	15,519	2,172	5,012	956
29 Sep 17	17,828	2,360	5,764	1,098
30 Jun 17	17,432	2,191	5,633	1,060
31 Mar 17	17,164	2,051	5,536	1,016
31 Dec 16	16,882	2,153	5,481	975
30 Sep 16	16,621	1,927	5,362	943
01 Jul 16	16,001	1,905	5,218	914
01 Apr 16	13,663	1,775	4,549	788
31 Dec 15	14,434	1,747	4,635	861
02 Oct 15	15,335	1,875	4,769	926
03 Jul 15	16,530	2,177	4,865	1,002
03 Apr 15	19,186	2,521	5,348	1,143
31 Dec 14	12,867	1,639	3,953	769
26 Sep 14	19,197	2,683	5,305	1,189
27 Jun 14	19,159	2,599	5,311	1,210
28 Mar 14	19,336	2,583	5,405	1,267
31 Dec 13	18,283	2,591	5,042	1,104
27 Sep 13	18,827	2,536	5,348	1,212
28 Jun 13	18,573	2,488	5,296	1,193

Ingresos de calidad: DHR tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(17.1%) de DHR son inferiores a los del año pasado (23.1%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de DHR han crecido un 16.8% al año en los últimos 5 años.

Acelerando crecimiento: DHR ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: DHR tuvo un crecimiento negativo de los beneficios (-29.4%) durante el año pasado, lo que dificulta la comparación con la media de la industria Life Sciences (-9.3%).

Rentabilidad financiera

Alta ROE: La rentabilidad financiera de DHR (7.6%) se considera baja.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Danaher Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Danaher Corporation to Report Q1, 2024 Results on Apr 23, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Danaher Corporation to Report Q4, 2023 Results on Jan 30, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Danaher Corporation to Report Q3, 2023 Results on Oct 24, 2023

Recent updates

Value Vs. Growth? Danaher Says Why Not Both?

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Danaher: All In On Life Sciences, And Market Update

Danaher Corporation to Report Q1, 2024 Results on Apr 23, 2024

Upcoming dividend of US$0.27 per share

Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?

Insider notifies of intention to sell stock

Dividend of US$0.27 announced

Danaher Corporation Approves Regular Quarterly Cash Dividend, Payable on April 26, 2024

Danaher Corporation, Annual General Meeting, May 07, 2024

Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Consensus EPS estimates fall by 11%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term

Now 20% overvalued after recent price rise

Is Danaher (NYSE:DHR) Using Too Much Debt?

Danaher Corporation Provides Earnings Guidance for the Fourth Quarter 2023

My Top 2024 Stock Pick: Danaher

Danaher Corporation to Report Q4, 2023 Results on Jan 30, 2024

Upcoming dividend of US$0.24 per share at 0.5% yield

Danaher Corporation (NYSE:DHR) completed the acquisition of Abcam plc (NasdaqGS:ABCM).

Danaher Corporation Announces Quarterly Dividend, Payable on January 26, 2024

Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles

RGA Investment Advisors - Danaher: Purity In The Crown Jewel Of Bioprocessing

Why Danaher Is One Of My Favorite Long-Term Investments

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates fall by 10%

Danaher: Short-Term Headwinds, But Long-Term Tailwinds

Now 20% undervalued after recent price drop

Upcoming dividend of US$0.27 per share at 0.5% yield

Danaher Corporation completed the Spin-Off of Veralto Corporation (NYSE:VLTO.WI).

Should Danaher Investors Sell New Veralto Shares?

Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Danaher Corporation to Report Q3, 2023 Results on Oct 24, 2023

Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund At Cost

Danaher Corporation Announces Quarterly Cash Dividend, Payable on October 27, 2023

Danaher: A Lost Year

Danaher Corporation (NYSE:DHR) entered into definitive agreement to acquire Abcam plc (NasdaqGS:ABCM) for $5.7 billion.

Levi & Korsinsky Notifies Danaher Corporation Investors of A Class Action Lawsuit and Upcoming Deadline

New minor risk - Insider selling

Lead Independent Director recently sold US$1.9m worth of stock

Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens

Executive Vice President notifies of intention to sell stock

Second quarter 2023 earnings: EPS misses analyst expectations

Danaher: A Compounding Icon At A Fair Price

Pomerantz LLP Announces Filing of Class Action Against Danaher Corporation

These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Danaher Corporation(NYSE:DHR) dropped from Russell 1000 Growth Index

Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump

Upcoming dividend of US$0.27 per share at 0.5% yield

Danaher Corporation to Report Q2, 2023 Results on Jul 25, 2023

At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?

Insider notifies of intention to sell stock

Danaher: A Great Chance To Buy This Long-Term Compounder

Danaher Corporation Approves Regular Quarterly Cash Dividend, Payable on July 28, 2023

Executive Vice President exercised options and sold US$1.9m worth of stock

Senior VP & Chief Science Officer recently sold US$121k worth of stock

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case

Co-Founder & Chairman exercised options to buy US$32m worth of stock.

Estimating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Upcoming dividend of US$0.27 per share at 0.4% yield

Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?

Is Danaher (NYSE:DHR) Using Too Much Debt?

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Danaher ups dividend by 8% to $0.27

Veralto Corporation Announces Management Appointments

Danaher Reportedly Expresses Takeover Interest in Catalent

Desglose de ingresos y gastos
Beta